Robert D. Allen III sold $29k of IVVD
Chief Scientific Officer at Invivyd, Inc.. 37,722 shares at an average of $0.78, traded Aug 17, 2026, filed Aug 18, 2026.
Score components
- +15RoleOfficer
- +5Trade size$29k at market
- +5Share of holdings soldSold 17% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-355911, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 15, 2026 | MOption exercise Common Stock10b5-1 | +102,000 | - | - | 216,487 | Aug 18, 2026 |
| Aug 17, 2026 | SOpen-market sale Common Stock10b5-1 | -20,679 | $0.72 | $15k | 195,808 | Aug 18, 2026 |
| Aug 18, 2026 | SOpen-market sale Common Stock10b5-1 | -17,043 | $0.84 | $14k | 178,765 | Aug 18, 2026 |
| Aug 15, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -102,000 | $0.00 | $0 | 0 | Aug 18, 2026 |
Related signals
Other insiders at Invivyd, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 7Weak | Invivyd, Inc. | Jill Andersen Chief Legal Officer, Secretary | $53k 67,962 shares | -19% | |
| 12Weak | Invivyd, Inc. | William E. Duke Chief Financial Officer | $32k 40,780 shares | -19% | |
| 5Weak | Invivyd, Inc. | Julie Green Chief Human Resources Officer | $32k 40,780 shares | -19% | |
| 5Weak | Invivyd, Inc. | Timothy Edward Lee Chief Commercial Officer | $32k 40,780 shares | -19% | |
| 7Weak | Invivyd, Inc. | Robert D. Allen III Chief Scientific Officer | $59k 37,581 shares | -25% | |
| 15Weak | Invivyd, Inc. | Jill Andersen Chief Legal Officer, Secretary | $106k 67,710 shares | -27% | |
| 20Weak | Invivyd, Inc. | William E. Duke Chief Financial Officer | $63k 40,627 shares | -27% | |
| 13Weak | Invivyd, Inc. | Julie Green Chief Human Resources Officer | $63k 40,627 shares | -27% | |
| 13Weak | Invivyd, Inc. | Timothy Edward Lee Chief Commercial Officer | $63k 40,627 shares | -26% | |
| 33Weak | IVVDbuy Invivyd, Inc. | Kevin F McLaughlin director | $125k 50,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.